Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;42:811-817
Published online before print August 11, 2003, doi: 10.1161/01.HYP.0000088363.65943.6C
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
42/4/811    most recent
01.HYP.0000088363.65943.6Cv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Callera, G. E.
Right arrow Articles by Tostes, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Callera, G. E.
Right arrow Articles by Tostes, R. C.
Related Collections
Right arrow Other hypertension

(Hypertension. 2003;42:811.)
© 2003 American Heart Association, Inc.


Scientific Contributions

ETA Receptor Blockade Decreases Vascular Superoxide Generation in DOCA-Salt Hypertension

Glaucia E. Callera; Rhian M. Touyz; Simone A. Teixeira; Marcelo N. Muscara; Maria Helena C. Carvalho; Zuleica B. Fortes; Dorothy Nigro; Ernesto L. Schiffrin; Rita C. Tostes

From the Department of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo (G.E.C., S.A.T., M.N.M., M.H.C.C., Z.B.F., D.N., R.C.T.), Sao Paulo, Brazil, and Clinical Research Institute of Montreal, University of Montreal (R.M.T., E.L.S.), Montreal, Canada.

Correspondence to Rita C.A. Tostes, University of Sao Paulo, Institute of Biomedical Science, Pharmacology Department, Av. Lineu Prestes, 1524, Sao Paulo, SP, 05508-900 Brazil. E-mail rtostes{at}usp.br

Development and progression of end-organ damage in hypertension have been associated with increased oxidative stress. Superoxide anion accumulation has been reported in deoxycorticosterone acetate (DOCA)-salt hypertension, in which endothelin-1 plays an important role in cardiovascular damage. We hypothesized that blockade of ETA receptors in DOCA-salt rats would decrease oxidative stress. Both systolic blood pressure (SBP, 210±9 mm Hg; P<0.05) and vascular superoxide generation in vivo were increased in DOCA-salt (44.9±10.3% of ethidium bromide–positive nuclei; P<0.05) versus control uninephrectomized (UniNx) rats (118±3 mm Hg; 18.5±3%, respectively). In DOCA-salt rats, the ETA antagonist BMS 182874 (40 mg/kg per day PO) lowered SBP (170±4 versus UniNx, 120±3 mm Hg) and normalized superoxide production (21.7±6 versus UniNx, 11.9±7%). Vitamin E (200 mg/kg per day PO) decreased superoxide formation in DOCA-salt rats (18.8±7%) but did not alter SBP. Oxidative stress in nonstimulated circulating polymorphonuclear cells (PMNs) or in PMNs treated with zymosan, an inducer of superoxide release, was similar in DOCA-salt and UniNx groups. Superoxide formation by PMNs was unaffected by treatment with BMS 182874. Western blot analysis showed increased nitrotyrosine-containing proteins in mesenteric vessels from DOCA-salt compared with UniNX. Treatment with either BMS 182874 or vitamin E abolished the differences in vascular nitrotyrosine-containing proteins between DOCA-salt and UniNX. Maximal relaxation to acetylcholine was decreased in DOCA-salt aortas (75.8±4.2% versus UniNx, 95.4±1.9%, P<0.05). BMS 182874 treatment increased acetylcholine-induced relaxation in DOCA-salt aortas to 93.5±4.5%. These in vivo findings indicate that increased vascular superoxide production is associated with activation of the endothelin system through ETA receptors in DOCA-salt hypertension, in apparently blood pressure–independent fashion.


Key Words: endothelin • receptors, endothelin • deoxycorticosterone • hypertension, arterial • oxidative stress




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
Q. Zeng, Q. Zhou, F. Yao, S. T. O'Rourke, and C. Sun
Endothelin-1 Regulates Cardiac L-Type Calcium Channels via NAD(P)H Oxidase-Derived Superoxide
J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 732 - 738.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. C. Viel, K. Benkirane, D. Javeshghani, R. M. Touyz, and E. L. Schiffrin
Xanthine oxidase and mitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive rats
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H281 - H288.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Just, C. L. Whitten, and W. J. Arendshorst
Reactive oxygen species participate in acute renal vasoconstrictor responses induced by ETA and ETB receptors
Am J Physiol Renal Physiol, April 1, 2008; 294(4): F719 - F728.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
T. M. Paravicini and R. M. Touyz
NADPH Oxidases, Reactive Oxygen Species, and Hypertension: Clinical implications and therapeutic possibilities
Diabetes Care, February 1, 2008; 31(Supplement_2): S170 - S180.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Xu, G. D. Fink, and J. J. Galligan
Increased sympathetic venoconstriction and reactivity to norepinephrine in mesenteric veins in anesthetized DOCA-salt hypertensive rats
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H160 - H168.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. A. Nath, L. V. d'Uscio, J. P. Juncos, A. J. Croatt, M. C. Manriquez, S. T. Pittock, and Z. S. Katusic
An analysis of the DOCA-salt model of hypertension in HO-1-/- mice and the Gunn rat
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H333 - H342.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. M. Sasser, J. C. Sullivan, J. L. Hobbs, T. Yamamoto, D. M. Pollock, P. K. Carmines, and J. S. Pollock
Endothelin A Receptor Blockade Reduces Diabetic Renal Injury via an Anti-Inflammatory Mechanism
J. Am. Soc. Nephrol., January 1, 2007; 18(1): 143 - 154.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. M. Paravicini and R. M. Touyz
Redox signaling in hypertension
Cardiovasc Res, July 15, 2006; 71(2): 247 - 258.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. C. Sullivan, J. S. Pollock, and D. M. Pollock
Superoxide-dependent hypertension in male and female endothelin B receptor-deficient rats.
Experimental Biology and Medicine, June 1, 2006; 231(6): 818 - 823.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
N. Dhaun, J. Goddard, and DavidJ. Webb
The Endothelin System and Its Antagonism in Chronic Kidney Disease
J. Am. Soc. Nephrol., April 1, 2006; 17(4): 943 - 955.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. E. Cingolani, M. C. Villa-Abrille, M. Cornelli, A. Nolly, I. L. Ennis, C. Garciarena, A. M. Suburo, V. Torbidoni, M. V. Correa, M. C. Camilionde Hurtado, et al.
The Positive Inotropic Effect of Angiotensin II: Role of Endothelin-1 and Reactive Oxygen Species
Hypertension, April 1, 2006; 47(4): 727 - 734.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
A. D. Smith, M. W. Brands, M.-H. Wang, and A. M. Dorrance
Obesity-induced hypertension develops in young rats independently of the Renin-Angiotensin-aldosterone system.
Experimental Biology and Medicine, March 1, 2006; 231(3): 282 - 287.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. M. Dorrance, N. C. Rupp, and E. F. Nogueira
Mineralocorticoid Receptor Activation Causes Cerebral Vessel Remodeling and Exacerbates the Damage Caused by Cerebral Ischemia
Hypertension, March 1, 2006; 47(3): 590 - 595.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Y. E. Lau, J. J. Galligan, D. L. Kreulen, and G. D. Fink
Activation of ETB receptors increases superoxide levels in sympathetic ganglia in vivo
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R90 - R95.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. J. Fuller and M. J. Young
Mechanisms of Mineralocorticoid Action
Hypertension, December 1, 2005; 46(6): 1227 - 1235.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Fenning, G. Harrison, R. Rose'meyer, A. Hoey, and L. Brown
L-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats
Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1408 - H1416.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. Brown
Cardiac extracellular matrix: a dynamic entity
Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H973 - H974.
[Full Text] [PDF]


Home page
Circ. Res.Home page
J. Rodriguez-Vita, M. Ruiz-Ortega, M. Ruperez, V. Esteban, E. Sanchez-Lopez, J. J. Plaza, and J. Egido
Endothelin-1, via ETA Receptor and Independently of Transforming Growth Factor-{beta}, Increases the Connective Tissue Growth Factor in Vascular Smooth Muscle Cells
Circ. Res., July 22, 2005; 97(2): 125 - 134.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. M. Pollock
Endothelin, Angiotensin, and Oxidative Stress in Hypertension
Hypertension, April 1, 2005; 45(4): 477 - 480.
[Full Text] [PDF]


Home page
HypertensionHome page
J. M. Williams, J. S. Pollock, and D. M. Pollock
Arterial Pressure Response to the Antioxidant Tempol and ETB Receptor Blockade in Rats on a High-Salt Diet
Hypertension, November 1, 2004; 44(5): 770 - 775.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. E. Callera, A. C. Montezano, R. M. Touyz, T. M.T. Zorn, M. H. C. Carvalho, Z. B. Fortes, D. Nigro, E. L. Schiffrin, and R. C. Tostes
ETA Receptor Mediates Altered Leukocyte-Endothelial Cell Interaction and Adhesion Molecules Expression in DOCA-Salt Rats
Hypertension, April 1, 2004; 43(4): 872 - 879.
[Abstract] [Full Text] [PDF]